University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream

Phase 2

Completed

Conditions: Anus Neoplasms

Interventions: Drug: AIJP (Arnebia Indigo Jade Pearl)
Drug: Placebo

First Posted Date: 2008-02-25

Last Posted Date: 2020-04-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 70

Registration Number: NCT00622440

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Treating Tobacco Dependence in Adolescents With Co-occurring Psychiatric Disorders

Phase 3

Completed

Conditions: Tobacco Use Disorder
Tobacco Use Cessation

First Posted Date: 2008-02-20

Last Posted Date: 2011-12-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT00618943

Locations: 🇺🇸
UCSF Langley Porter Psychiatric Institute, San Francisco, California, United States
🇺🇸
Edgewood Center for Children and Families, San Bruno, California, United States
🇺🇸
San Mateo County Mental Health, San Mateo, California, United States

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Phase 2

Completed

Conditions: Recurrent Central Nervous System Neoplasm

Interventions: Drug: temozolomide

First Posted Date: 2008-02-20

Last Posted Date: 2018-01-31

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT00619112

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger

Phase 4

Completed

Conditions: Chlamydia Trachomatis
Trachoma

Interventions: Drug: Azithromcyin
Drug: Azithromycin

First Posted Date: 2008-02-20

Last Posted Date: 2012-05-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1139

Registration Number: NCT00618449

Locations: 🇺🇸
Chlamydia Research Laboratory, San Francisco, California, United States
🇳🇪
Programme National de Lutte Contre la Cécité, Niamey, Niger

Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases

Phase 2

Completed

Conditions: Breast Cancer
Metastatic Cancer

Interventions: Drug: irinotecan hydrochloride
Drug: temozolomide

First Posted Date: 2008-02-18

Last Posted Date: 2018-04-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT00617539

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer

Phase 1

Terminated

Conditions: Breast Cancer

Interventions: Drug: cyclophosphamide
Drug: methotrexate
Drug: sunitinib malate
Other: laboratory biomarker analysis

First Posted Date: 2008-02-15

Last Posted Date: 2020-01-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 32

Registration Number: NCT00616122

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV

Not Applicable

Completed

Conditions: HIV

Interventions: Behavioral: Counseling sessions
Behavioral: Group workshop

First Posted Date: 2008-02-11

Last Posted Date: 2014-12-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 219

Registration Number: NCT00611429

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Dyspnea in Patients With Pulmonary Fibrosis

Completed

Conditions: Pulmonary Fibrosis

First Posted Date: 2008-02-08

Last Posted Date: 2013-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT00611182

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

HIV and Hepatitis Care Coordination in Methadone Treatment

Not Applicable

Completed

Conditions: Hepatitis, Viral, Human
HIV Infections

Interventions: Behavioral: Testing, Education, & Counseling (TEC)
Behavioral: Hepatitis Care Coordination (HCC)

First Posted Date: 2008-02-06

Last Posted Date: 2013-01-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 489

Registration Number: NCT00608192

Locations: 🇺🇸
Beth Israel Medical Center Methadone Maintenance Program, New York, New York, United States
🇺🇸
San Francisco General Hospital Opiate Treatment Outpatient Program, San Francisco, California, United States

Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma

Phase 4

Completed

Conditions: Asthma

Interventions: Drug: Fluticasone

First Posted Date: 2008-02-01

Last Posted Date: 2014-03-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 44

Registration Number: NCT00606242

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy